Background
Owing to the broad and heterogeneous population of patients with acute coronary syndromes (ACS), early risk stratification is highly recommended to guide therapeutic management and improve outcome (European Society of Cardiology [ESC] guidelines) [1] . Age, Killip class, heart rate and systolic blood pressure have been identified as powerful indicators of risk [2, 3] . When combined with electrocardiography, creatinine and troponin concentrations, these variables can be modelled into an easy-to-use score to further improve risk stratification. The Global Registry of Acute Coronary Events (GRACE) risk score [2] has been recommended as a decision-making algorithm for the management of ACS patients (ESC guidelines) [1] .
It is relevant for clinicians to know whether patient outcome can be improved by implementing additional easyto-capture features. Anaemia, an independent correlate of survival [4] , is present in up to 43% of the elderly population presenting with an ACS but is not considered in the GRACE score.
Our aim was to assess whether anaemia can improve the predictability of the GRACE score in a prospective cohort of 'real-life' patients hospitalized with an ACS.
Methods

Study population and follow-up
Data from 1064 consecutive patients with ST-segment elevation or non-ST-segment elevation ACS admitted between 2009 and 2010 to two tertiary care centres (CHRU Lille and CHU La Pitié) were prospectively collected. ACS was defined using the ESC/American College of Cardiology guidelines [5, 6] . Exclusion criteria were mechanical ventilation or initial cardiac arrest, significant valvular heart disease, bleeding events before ACS and postoperative ACS. Blood samples were drawn for serum creatinine and haemoglobin concentration determinations on admission. Anaemia was defined according to the World Health Organization definition (haemoglobin < 13 mg/dL in men or < 12 mg/dL in women) [7] . Serum haemoglobin concentrations were obtained using a commercially available device (Beckmann Coulter Automated CBC Analyzer; Beckman Coulter, Inc., Fullerton, CA, USA). The glomerular filtration rate (GFR) was estimated using the four-component Modification of Diet in Renal Disease equation [8] . The GRACE risk score model includes the following weighted variables: age, heart rate and systolic blood pressure on presentation, congestive heart failure Killip class, ST-segment deviation, initial serum creatinine concentration, elevated cardiac enzymes and cardiac arrest at admission [2] .
The status of the patients was monitored by telephone calls to referring cardiologists and primary care physicians, and by review of the medical records; data were collected as part of their routine evaluation at baseline and at clinical follow-up. Informed consent for access to protected health information was obtained. The registry was declared to the Commission Nationale de l'Informatique et des Libertés (CNIL).
Endpoint
The primary endpoint, as in the GRACE report, was a composite of death and rehospitalization for myocardial infarction (MI), including ST-segment elevation MI or non-ST-segment elevation MI, 6 months after admission.
Statistical analysis
Continuous variables are expressed as mean ± standard deviation or median [25th;75th percentiles], as appropriate. Categorical variables are presented as absolute numbers and percentages. Baseline characteristics of subjects with anaemia were compared with those of subjects without anaemia using the Chi-square test or Fisher's test for categorical variables and Student's t-test for continuous variables.
Event-free survival curves were estimated using the Kaplan-Meier method and compared using the log-rank test. Median follow-up time was estimated with the reverse Kaplan-Meier method. Univariate followed by multivariable Cox analyses were performed to identify independent predictors of MI or death. The log-linearity assumption for continuous variables and the proportional hazard assumption were tested by supremum tests. In case of violation of the former assumption, the continuous variable was dichotomized, the cut-off value being visually established; in case of violation of the latter assumption, a piecewise model was used to model the hazard ratio (HR) as a step function of time, the cut-off value again being visually established. Owing to non-proportional hazards for the GRACE score, prognostic factors of event-free survival were identified beyond 15 days of admission for patients who remained alive and/or without any new MI (leading to a sample of 1003 subjects).
To assess the incremental value of anaemia over the GRACE score on event-free survival beyond a 15-day followup period, improvement in model performance was assessed by: Schwarz's Bayesian criterion with the likelihood ratio test to evaluate the contribution of anaemia to the model combining anaemia with GRACE; change in Harrell's cstatistics; change in Kent and O'Quigley's 2 ; and, following Chambless et al. [9] , integrated discrimination improvement (IDI) and the continuous version of net reclassification improvement (cNRI) for censored data. These analyses were carried out in the sample of 1003 subjects (training sample).
For illustrational purposes, a category-based NRI was computed, with a risk of event defined as low, intermediate and high for an estimated cumulative incidence of ≤ 5%, > 5-10% and > 10%, respectively. For each category of risk based on the GRACE score alone, Kaplan-Meier event-free survival curves were plotted according to the reclassification with anaemia.
Internal validity of the model including anaemia was estimated by bootstrapping techniques. Two thousand bootstrap samples of 1003 subjects were generated and Harrell's cstatistics, Kent and O'Quigley's 2 , the IDI and the cNRI were computed in each of the 2000 samples. For each performance index, given numbers are the mean of the 2000 estimates and 95% bootstrap confidence intervals, where the lower and upper bounds are the 2.5% and 97.5% percentiles of the resampling distribution, respectively.
A two-tailed type I error rate less than 0.05 was considered for statistical significance. Analyses were conducted using SAS software (SAS version 9.1, SAS Institute Inc., Cary, NC, USA).
Results
Study population
A total of 1064 patients with ACS were included in the present prospective observational registry. Most patients were men, 54% were hypertensive, 24% had diabetes mellitus, 17% had Killip class greater or equal to 2 and anaemia was diagnosed in 29% of patients on admission (Table 1) . Fig. 1 shows the distribution of serum haemoglobin at admission in the study population. Fifty-seven per cent had ST-segment elevation MI, 38% received glycoprotein IIb/IIIa inhibitors and 12% received fibrinolytic therapy. Coronary angiography was performed in most patients; primary percutaneous coronary intervention was the first reperfusion (10) 59 (8) 46 (15) 3 53 (5) 23 (3) 30 (10) 4 23 (2) 13 (2) 10 ( strategy in 48% and coronary artery bypass graft surgery was performed in 7% of the population.
Clinical and biological correlates of anaemia on admission
Older age, female sex, history of coronary artery disease, hypertension, diabetes mellitus and higher Killip class were associated with anaemia on admission ( Table 1) . Anaemia was more prevalent in patients without a history of smoking and in patients with non-ST-segment elevation ACS. Heart rate was slightly higher in patients with anaemia compared with in others. Prior use of aspirin and clopidogrel was associated with anaemia on admission, while fibrinolytic and glycoprotein IIb/IIIa receptor blockade therapies were used less frequently in patients with anaemia. Coronary angiography was performed less frequently in patients with anaemia than in those without anaemia. Patients with anaemia more frequently had impaired renal function, as demonstrated by the reduced estimated GFR (Table 1) . Lastly, patients with anaemia had a higher GRACE score than those without.
Follow-up
There were 132 events during follow-up, including 68 deaths (Table 1) . Anaemia was more frequent in patients who experienced an event compared with in others (HR 3.008, 95% confidence interval [CI] 2.137-4.234; P < 0.0001). Eventfree survival according the presence of anaemia is presented in Fig. 2 . Older age, female sex, history of coronary artery disease (CAD), diabetes mellitus, ST-segment elevation MI, Killip class ≥ 2, increased heart rate and low blood pressure were also associated with the risk of death during follow-up. Impaired renal function and higher peak cardiac troponin I were associated with poor outcome ( Table 2 ). Lack of use of coronary angiography or prior use of antiplatelet therapy was also associated with poorer outcome. As expected, a higher GRACE score predicted poor outcome (beyond 2 weeks of follow-up: HR 1.036, 95% CI 1.022-1.049; P < 0.0001). No interaction was found between anaemia and age for predicting outcome (P for interaction = 0.62); hence, no further subgroup analysis based on age was carried out. By multivariable Cox analysis without including the GRACE risk score (Table 3) , multivessel CAD, impaired renal function and anaemia were found to be independently associated with outcome. Table 4 shows that the combined model of anaemia plus the GRACE score had a better predictive value than the GRACE score alone, as demonstrated by better global fit and calibration. In addition, improvements in discrimination by model 2 were confirmed by the IDI at 2.3%, suggesting a further average separation of events from non-events of 2.3% (Table 4) . Addition of anaemia to the GRACE score model led to a significant net reclassification of patients in the appropriate directions. Accordingly, the continuous category-free NRI was high at 62.2%, with the contribution of 12.5% patients who experienced an event and 49.7% patients who did not experience an event being reclassified. Reclassification was achieved in 49.7% of patients who did not experience an event but in only 12.5% of patients who experienced an event. Potential for clinical benefit achieved when anaemia was combined with the GRACE score was assessed using the category-based NRI. Reclassifications are summarized in Table 5 . As depicted in the Methods section, we used 5% and 10% as thresholds (overall event rate 13%) to define patients as being at low, intermediate and high risk according to the GRACE score. Hence, as depicted in Fig. 3 , of 206 patients categorized as low risk by the GRACE score, 34 were reclassified into different categories (16.5%), 27 being reclassified as intermediate risk (observed event rate 7.4%) and seven as high risk (observed event rate 28.6%). Of the 584 patients categorized as intermediate risk by the GRACE score, 464 were reclassified into different categories (79.5%), 324 being reclassified as low risk (observed event rate 4%) and 140 as high risk (observed event rate 14.3%). Of the 213 patients categorized as high risk by the GRACE score, 97 (45.5%) were downgraded into intermediate risk (observed event rate 8.2%). Overall, 174 patients were reclassified into a higher risk category (17.3%) and 421 into a lower risk category (41.9%). As for the continuous NRI, the category-based NRI of 30.8% was mainly determined by 27.1% of patients who did not experience an event and only 3.7% of patients who experienced an event. In other words, the composite score based on GRACE score + anaemia had a better predictive value in nonevent patients, underlying the overestimation of risk by the GRACE score alone. Fig. 4A -C shows survival curves of patients reclassified by the composite of GRACE score plus anaemia according to their original category of GRACE risk score.
Internal validity of the combined model over the GRACE score alone was ultimately validated by bootstrapping techniques, with findings similar to those obtained with previous analysis (Table 6 ). 
Discussion
Our data demonstrate that in a prospective cohort of consecutive patients hospitalized for an ACS, anaemia is associated with a three-fold increased risk of death or MI at 6-month follow-up. Anaemia provided additional prognostic information over the GRACE score. Importantly, the addition of anaemia to the GRACE score allows for reclassification of an important proportion of the study population into a lower risk category (421 patients; 42%). Besides creatinine and cardiac troponin, haemoglobin may deserve to be routinely incorporated into the risk stratification of patients with an ACS, to improve risk stratification and long-term event prediction. Haemoglobin concentration is a powerful predictive factor for mortality and morbidity in patients with ACS [10] [11] [12] but also with various other illnesses, including heart failure [13] , kidney dysfunction [14] and the whole spectrum of CAD [15, 16] . Anaemia, present in one-third of ACS patients in agreement with previous studies [17, 18] , predicted a worse prognosis. Anaemia not only decreases oxygen delivery to the injured myocardium and periphery, associated with the risk of increased infarct size, arrhythmias and hypotension, but is also an integrator of comorbid conditions, such as older age, diabetes and kidney dysfunction. Therapies aimed at correcting anaemia, the haemoglobin value threshold at which to treat and the target haemoglobin value still remain sources of investigation and debate. The comprehensive GRACE score combines factors that were found to be associated independently with increased mortality, including age, heart rate, systolic blood pressure, ST-segment deviation, serum creatinine and cardiac troponin, cardiac arrest at presentation and Killip class. Meneveau et al. [18] reported previously that anaemia on admission provided independent prognostic information on top of the GRACE score for the prediction of mortality or MI in ACS patients at 1-month follow-up. In contrast, we looked at 6-month clinical outcome, as in the GRACE score system. This study, like that of Meneveau et al., demonstrates clearly the clinical significance of combining anaemia with the GRACE score for predicting outcome in ACS patients. Hence, risk estimate using the GRACE score alone was inappropriate in an important proportion of ACS patients. Adding anaemia to the GRACE score led to a substantial reclassification of ACS patients into a lower risk category (42% of the study cohort). The accuracy of the combined model for predicting clinical outcome was much better than that of the GRACE score alone.
Study limitations
This study, which included a relatively small number of ACS patients, may represent an initial proof of concept in the evaluation process of a novel marker of cardiovascular disease risk [19] ; another larger prospective cohort is needed to give external validity to the present results. However, the robust statistical approach with bootstrap techniques demonstrates that a systematic improvement in model fit, calibration and discrimination may be expected when combining anaemia with the GRACE score. The clinical significance of this improvement is clearly illustrated by divergent survival curves among reclassified patients with different risk categories. Bleeding events [20, 21] and transfusion [22] , both of which have been shown to affect outcome, were not specifically studied. Lastly, the cause of the anaemia (occult bleeding, chronic kidney dysfunction, malignancy, inflammation, thyroid dysfunction, etc.) was not thoroughly investigated.
Conclusion
Anaemia on admission is a strong independent risk of poor 6-month outcome in ACS patients. Adding anaemia appears to refine the GRACE score, which often overestimates the risk. Our study, combined with others, strongly suggests that anaemia should be integrated into the risk stratification beyond the GRACE score in ACS patients. Further validation in large prospective multicentre registries is needed to justify the inclusion of anaemia in a better-performing modified GRACE score.
